Margaret McLain, NP
Nurse Practitioner · Coos Bay, ORNPI 1578601282
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by AbbVie at 25.7% of the total. Reporting peaked in 2024 at $2,462 and has fallen 73.3% since, to $658 in 2025. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $55.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
- Merz North America, Inc.$2K
- Medtronic$2K
- Revance Therapeutics, Inc.$254
- Abbott$81
- plus $196 from 7 others
What the payments were for
- Speaking & faculty fees$2,50033%
- Travel & lodging$1,41119%
- Food & beverage$3,62948%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $1,935 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $1,796 |
| Merz North America, Inc. | 50 | $1,685 |
| Medtronic | 14 | $1,594 |
| Revance Therapeutics, Inc. | 6 | $254 |
| Abbott | 1 | $81 |
| Galderma Laboratories, L.p. | 2 | $67 |
| Edwards Lifesciences | 1 | $27 |
| W. L. Gore & Associates, Inc. | 1 | $24 |
| AstraZeneca | 1 | $24 |
| Novartis | 1 | $20 |
| Irhythm Technologies, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,541 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 91 | $86,969 |
| JardianceEmpagliflozin | 27 | $19,363 |
| EntrestoSacubitril/Valsartan | 11 | $11,743 |
| Ranolazine ErRanolazine | 36 | $2,618 |
| Metoprolol Succinate | 93 | $1,632 |
| Flecainide Acetate | 12 | $1,438 |
| Amiodarone Hcl | 36 | $890 |
| Atorvastatin Calcium | 48 | $673 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 28 | $565 |
| ClopidogrelClopidogrel Bisulfate | 34 | $536 |
| Lisinopril | 35 | $510 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $494 |
| Losartan Potassium | 36 | $307 |
| Metoprolol Tartrate | 31 | $260 |
| Furosemide | 35 | $210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $20 | $11,74311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 997 nurse practitioner providers in Oregon.
Other nurse practitioner in Coos Bay
- Davina BledsoeCoos Bay$2K
- Jason EmpsonCoos Bay$2K
- Alicia DuyvejonckSpringfield$299K
- Summer HarnessLake Oswego$113K
- Alana WilsonPortland$58K
- Jennifer MurdochPortland$15K
- Berhane MebratuPortland$10K
- Desiree CihelkaSpringfield$8K
- Amy CarterPortland$8K
- Mallory CrownoverSpringfield$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.